318 related articles for article (PubMed ID: 25904023)
1. The Use of HCG-Based Combination Therapy for Recovery of Spermatogenesis after Testosterone Use.
Wenker EP; Dupree JM; Langille GM; Kovac J; Ramasamy R; Lamb D; Mills JN; Lipshultz LI
J Sex Med; 2015 Jun; 12(6):1334-7. PubMed ID: 25904023
[TBL] [Abstract][Full Text] [Related]
2. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study.
Hussein A; Ozgok Y; Ross L; Rao P; Niederberger C
BJU Int; 2013 Mar; 111(3 Pt B):E110-4. PubMed ID: 22958644
[TBL] [Abstract][Full Text] [Related]
3. Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy.
Kohn TP; Louis MR; Pickett SM; Lindgren MC; Kohn JR; Pastuszak AW; Lipshultz LI
Fertil Steril; 2017 Feb; 107(2):351-357.e1. PubMed ID: 27855957
[TBL] [Abstract][Full Text] [Related]
4. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy.
Hsieh TC; Pastuszak AW; Hwang K; Lipshultz LI
J Urol; 2013 Feb; 189(2):647-50. PubMed ID: 23260550
[TBL] [Abstract][Full Text] [Related]
5. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone.
Bouloux PM; Nieschlag E; Burger HG; Skakkebaek NE; Wu FC; Handelsman DJ; Baker GH; Ochsenkuehn R; Syska A; McLachlan RI; Giwercman A; Conway AJ; Turner L; van Kuijk JH; Voortman G
J Androl; 2003; 24(4):604-11. PubMed ID: 12826700
[TBL] [Abstract][Full Text] [Related]
6. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.
Matsumoto AM; Karpas AE; Bremner WJ
J Clin Endocrinol Metab; 1986 Jun; 62(6):1184-92. PubMed ID: 3084535
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men.
Liu PY; Turner L; Rushford D; McDonald J; Baker HW; Conway AJ; Handelsman DJ
Hum Reprod; 1999 Jun; 14(6):1540-5. PubMed ID: 10357972
[TBL] [Abstract][Full Text] [Related]
8. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience.
Yang L; Zhang SX; Dong Q; Xiong ZB; Li X
Int Urol Nephrol; 2012 Apr; 44(2):393-9. PubMed ID: 21989858
[TBL] [Abstract][Full Text] [Related]
9. Fertility outcomes in men with prior history of anabolic steroid use.
Ledesma BR; Weber A; Venigalla G; Muthigi A; Thomas J; Narasimman M; White J; Ramasamy R
Fertil Steril; 2023 Dec; 120(6):1203-1209. PubMed ID: 37769866
[TBL] [Abstract][Full Text] [Related]
10. Follicle-stimulating hormone and human spermatogenesis.
Bremner WJ; Matsumoto AM; Sussman AM; Paulsen CA
J Clin Invest; 1981 Oct; 68(4):1044-52. PubMed ID: 6793629
[TBL] [Abstract][Full Text] [Related]
11. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.
Warne DW; Decosterd G; Okada H; Yano Y; Koide N; Howles CM
Fertil Steril; 2009 Aug; 92(2):594-604. PubMed ID: 18930225
[TBL] [Abstract][Full Text] [Related]
12. [Risk of Male Infertility Due to Testosterone Replacement Therapy for Late-Onset Hypogonadism (LOH)].
Sukegawa G; Tsuji Y
Hinyokika Kiyo; 2020 Nov; 66(11):407-409. PubMed ID: 33271659
[TBL] [Abstract][Full Text] [Related]
13. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
[TBL] [Abstract][Full Text] [Related]
14. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
15. Human chorionic gonadotrophin treatment prior to microdissection testicular sperm extraction in non-obstructive azoospermia.
Shiraishi K; Ohmi C; Shimabukuro T; Matsuyama H
Hum Reprod; 2012 Feb; 27(2):331-9. PubMed ID: 22128297
[TBL] [Abstract][Full Text] [Related]
16. Hormonal therapy (hCG and rhFSH) for infertile men with adult-onset idiopathic hypogonadotropic hypogonadism.
Kobori Y; Suzuki K; Iwahata T; Shin T; Sato R; Nishio K; Yagi H; Arai G; Soh S; Okada H
Syst Biol Reprod Med; 2015 Apr; 61(2):110-2. PubMed ID: 25518839
[TBL] [Abstract][Full Text] [Related]
17. The effect of human chorionic gonadotropin-based hormonal therapy on intratesticular testosterone levels and spermatogonial DNA synthesis in men with non-obstructive azoospermia.
Shinjo E; Shiraishi K; Matsuyama H
Andrology; 2013 Nov; 1(6):929-35. PubMed ID: 24123916
[TBL] [Abstract][Full Text] [Related]
18. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
[TBL] [Abstract][Full Text] [Related]
19. [Stimulation of a spermatogenesis in men at a pathospermia and infertility].
Rozhivanov RV; Kravtsova NS; Kurbatov DG
Urologiia; 2016 Mar; (1 Suppl 1):54-58. PubMed ID: 28247748
[TBL] [Abstract][Full Text] [Related]
20. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
